Do I Qualify?
Michael Atar's avatarPerson

Michael Atar

MEDICAL TECHNOLOGY INVESTOR AND ENTREPRENEURcytovale

United Kingdom

Member Since May 2022

Published content

14 Effective Strategies for Connecting With Peers Without Comparing Your Successes

expert panel

Having a deep understanding of yourself and your own goals can help prevent feelings of inadequacy. From Instagram and Twitter to now even LinkedIn, having a presence online today means constantly reading about what everyone has going on. This includes the life updates that people typically post but social media has also increased people’s tendency to primarily share the highlights rather than the entire picture. While this is not a bad thing on its own, constantly viewing the success of your peers can amplify your own feelings of inadequacy around personal and professional failures. Simply deciding to take a step back is one approach to consider, but it can negatively impact your relationships with peers over time. Below, 14 Newsweek Expert Forum members share recommendations for how professionals can connect and maintain healthy relationships with peers without comparing themselves to others’ success and accomplishments.

3 Dangers of Entitlement

article

There is nothing inherently bad about power — what matters is what you do with it.

The Art of Invention: Why Creativity Is Essential to Advance STEM

article

There is a bigger lesson we all can learn from studying, appreciating and taking in the arts.

Finding Your Niche Through Interdisciplinary Interests 

article

A flexible mindset can allow for unorthodox connections and unexpected opportunities.

Company details

cytovale

Company bio

Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Our investigational IntelliSep test is pioneering a new way of quickly and accurately analyzing white blood cells to stratify a patient’s risk of sepsis by performing a biomechanical evaluation of white blood cells collected from a standard blood draw in under 10 minutes. Cytovale’s first market application will be for sepsis, one of the fastest-moving, most lethal conditions in the world. Sepsis, a dysregulated immune response to infection, is often difficult to quickly and accurately diagnose. Sepsis is the no. 1 cause of death in hospitals, taking the lives of 270,000 people every year in the U.S. – more than opioid overdoses, prostate cancer, and breast cancer combined. Mortality from sepsis increases as much as eight percent with every hour of delayed treatment, and as much as 80 percent of sepsis deaths could be prevented with rapid diagnosis and treatment, making early detection essential. Cytovale aims to provide critical insight for early identification of patients at risk of having sepsis, in the time needed for it to be useful. Follow us on Twitter: twitter.com/cytovale Subscribe to our newsletter: http://eepurl.com/huCdiH

Industry

Technology

Company size

11 - 50

This member is no longer active.

Do you have important ideas that you want to share with the world?

Click below to learn more about our vetted network of experts and publication opportunities on Newsweek.com.
Explore Newsweek Expert ForumView Membership Qualifications
Newsweek Expert Forum is a vetted professional organization of senior executives, speakers, authors and academic leaders who are changing the world through idea sharing and education.